M D Gammage
Affiliation: University of Birmingham
- Selective site pacing: defining and reaching the selected siteRandy Lieberman
Division of Cardiology and Electrophysiology, Harper Hospital, Detroit, Michigan, USA
Pacing Clin Electrophysiol 27:883-6. 2004..This lack of definition consensus may have contributed to the apparent conflict of data, particularly in the right ventricle. There is an urgent need for a standardization of terms and identifying measures for selective pacing sites...
- Fifty years of permanent pacemakers: chronotropic rescue to inotropic supportMichael D Gammage
The Medical School, University of Birmingham
Clin Med 8:176-7. 2008
- Tilt testing: a useful screen for rate-drop responseM D Gammage
Department of Cardiovascular Medicine, University of Birmingham, United Kingdom
Pacing Clin Electrophysiol 20:829-31. 1997..Careful analysis of the pattern of blood pressure and heart rate response during the tilt test may allow selection of those patients likely to respond to RDR and may provide useful information for initial programming of the algorithm...
- Rate-drop response programmingM D Gammage
Department of Cardiovascular Medicine, University of Birmingham, United Kingdom
Pacing Clin Electrophysiol 20:841-3. 1997..Effective therapeutic settings are likely to result in an excess of pacing interventions; these, however, tend to be less symptomatic than the syncope or presyncope suffered by the patient and are generally well tolerated or not noticed...
- Experience with a lead fixation/suture sleeveM D Gammage
University of Birmingham, United Kingdom
Pacing Clin Electrophysiol 21:549-52. 1998..There have been no complaints of patient discomfort. We conclude that this device is safe and effective and offers a significant advance in lead fixation...
- External cardioversion in patients with implanted cardiac devices: is there a problem?Michael D Gammage
Department of Cardiovascular Medicine, The Medical School, University of Birmingham, Edgbaston, Birmingham, UK
Eur Heart J 28:1668-9. 2007
- Association between serum free thyroxine concentration and atrial fibrillationM D Gammage
Department of Cardiovascular Medicine, University of Birmingham, Birmingham, England
Arch Intern Med 167:928-34. 2007..Our objective was to determine the relationship between thyroid function and presence of atrial fibrillation (AF) in older subjects...
- Randomized trials for selective site pacing: do we know where we are going?Michael D Gammage
Department of Cardiovascular Medicine, Center for Cardiovascular Sciences, University of Birmingham and University Hospital Birmingham, Edgbaston, Birmingham, United Kingdom
Pacing Clin Electrophysiol 27:878-82. 2004....
- Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithmH J Marshall
Department of Cardiovascular Medicine, University of Birmingham, Birmingham
Circulation 99:1587-92. 1999..However, few data demonstrate its superiority over continued medical therapy. The influence of pacing mode and mode-switch algorithm has not been investigated...
- Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic menI Rajman
Department of Medicine, Queen Elizabeth Hospital Birmingham, UK
Atherosclerosis 125:231-42. 1996..LDL score was significantly correlated with CAD, even after adjusting for triglyceride and HDL cholesterol concentrations and it was the best discriminant factor for the presence of CAD...
- Thyroid disease and its treatment: short-term and long-term cardiovascular consequencesF Osman
Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK
Curr Opin Pharmacol 1:626-31. 2001..Increasing evidence suggests that long-term vascular morbidity and mortality occurs in both overt and subclinical thyroid disease...
- Ablate and pace revisited: long term survival and predictors of permanent atrial fibrillationA Queiroga
The University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK
Heart 89:1035-8. 2003..To assess long term mortality and identify factors associated with the development of permanent atrial fibrillation after atrioventricular (AV) node ablation for drug refractory paroxysmal atrial fibrillation...
- Indications and nonindications for ablation of atrioventricular conduction in the elderly: is it sensible to destroy normal tissue?Howard J Marshall
University Hospital Birmingham, Birmingham B15 2TH, United Kingdom
Am J Geriatr Cardiol 11:365-9. 2002..In conclusion, ablation and pacing offers symptomatic and functional benefit to patients with drug-refractory atrial fibrillation. Timing of the intervention relates to response to other pharmacologic therapy...
- Treatment of amiodarone-associated thyrotoxicosisJayne A Franklyn
Institute of Biomedical Research, The Medical School, University of Birmingham, UK
Nat Clin Pract Endocrinol Metab 3:662-6. 2007..A 75-year-old man had a myocardial infarction complicated by poor left ventricular function and non-sustained ventricular tachycardia. He began treatment with amiodarone and 12 months later developed symptoms of thyrotoxicosis...
- Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional surveySue Wilson
Department of Primary Care and General Practice, University of Birmingham, Edgbaston, Birmingham, B15 2TT, United Kingdom
J Clin Endocrinol Metab 91:4809-16. 2006..Population-based screening has been advocated for subclinical thyroid dysfunction in the elderly because the disorder is perceived to be common, and health benefits may be accrued by detection and treatment...
- Heart rate variability and turbulence in hyperthyroidism before, during, and after treatmentFaizel Osman
Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham B15 2TH, United Kingdom
Am J Cardiol 94:465-9. 2004..This study is the first to evaluate HRT in overt and treated hyperthyroidism...
- Successful treatment of amiodarone-induced thyrotoxicosisFaizel Osman
Division of Medical Sciences, University of Birmingham, Birmingham, UK
Circulation 105:1275-7. 2002..Amiodarone-induced thyrotoxicosis (AIT) is a difficult management problem about which there are little published data. We examined whether continuing amiodarone or differentiating AIT into 2 subtypes affected outcome...
- Multi-center clinical experience with a lumenless, catheter-delivered, bipolar, permanent pacemaker lead: implant safety and electrical performanceMichael D Gammage
Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK
Pacing Clin Electrophysiol 29:858-65. 2006..1-Fr pacing lead. Implantation can be performed in a variety of right heart sites using a deflectable catheter (Model 10600, Medtronic). Lead performance and safety were studied...
- Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control studyFaizel Osman
Division of Medical Sciences, University of Birmingham, Edgbaston, Birmingham, England
J Am Coll Cardiol 49:71-81. 2007..This study sought to prospectively evaluate the prevalence of cardiovascular abnormalities in patients with overt hyperthyroidism before and after antithyroid therapy...
- Clinical review 142: cardiac dysrhythmias and thyroid dysfunction: the hidden menace?Faizel Osman
Division of Medical Sciences, Queen Elizabeth Hospital, University of Birmingham, Birmingham, United Kingdom B15 2TH
J Clin Endocrinol Metab 87:963-7. 2002..Improved detection of supraventricular dysrhythmias and therapeutic intervention (e.g. anticoagulants, antiarrhythmics) may improve the long-term vascular prognosis, but their role remains to be established in large therapeutic trials...
- Hyperthyroidism and cardiovascular morbidity and mortalityFaizel Osman
Department of Cardiovascular Medicine, Queen Elizabeth Hospital, University of Birmingham, Edgbaston, Birmingham, England
Thyroid 12:483-7. 2002....
- Base over apex: does site matter for pacing the right ventricle?Michael D Gammage
Europace 10:572-3. 2008
- Selective site pacing: the future of cardiac pacing?Harry G Mond
Pacing Clin Electrophysiol 27:835-6. 2004